Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of September 2020. The registrant's principal executive offices are located in Beijing, People's Republic of China. The filing is made pursuant to Rule 13a-16 under the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a regulatory notice regarding compliance status rather than a financial results report.
Material Changes and Unusual Items
The primary material event disclosed in this filing is the company regaining compliance with the Nasdaq Minimum Bid Price Requirement. This information is detailed in the attached press release (Exhibit 99.1).
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary on future operations, or a discussion of risks and contingencies beyond the context of the Nasdaq compliance issue.
Investor Verification Checklist
- Verify the current Nasdaq Minimum Bid Price status of Hexindai Inc. shares.
- Review the full text of the press release (Exhibit 99.1) for details on the compliance mechanism.
- Confirm the discrepancy between the requested company name ("Akso Health Group") and the actual registrant in the filing ("Hexindai Inc.").
- Check subsequent filings for any financial data, as this 6-K contains no financial metrics.